Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Neurology | Psychiatry/Psychology | Family Medicine

Attention Deficit/Hyperactivity Disorder (ADHD - Adults) Clinical Trials

A listing of Attention Deficit/Hyperactivity Disorder (ADHD - Adults) medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 6 Last 

Alabama

Nelson Handal
Dothan Alabama 36303
Updated

A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder

Arizona

Melmed Center
Scottsdale Arizona 85254
Updated

A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder

Wen Cal
Tucson Arizona 85719
Updated

A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder

Arkansas

Clinical Study Centers, LLC
Little Rock Arkansas 72211
Updated

A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder

Clinical Study Centers, LLC
Little Rock Arkansas 72211
Updated

A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder

California

Pharmacology Research Institute, Encino
Encino California 91316

This is a Phase 2 Randomized, Double-Blind, Parallel-Group, Multicenter Efficacy and Safety Study of SEP-225289 versus Placebo in Adults with Attention Deficit Hyperactivity Disorder (ADHD)

Pharmacology Research Institute, Los Alamitos
Los Alamitos California 90720

This is a Phase 2 Randomized, Double-blind, Parallel-Group, Multicenter Efficacy and Safety Study of SEP-225289 versus Placebo in Adults with Attention Deficit Hyperactivity Disorder (ADHD)

Pharmacology Research Institute, Newport Beach
Newport Beach California 92660

This is a Phase 2 Randomized, Double-blind, Parallel-Group, Multicenter Efficacy and Safety Study of SEP-225289 versus Placebo in Adults with Attention Deficit Hyperactivity Disorder (ADHD)

Elite Clinical Trials, Inc.
Wildomar California 92595

Are you an adult with ADHD who has been taking medication for the past 6 months? You may be eligible to participate in a research study for an FDA approved medication.

Elite Clinical Trials, Inc.
Wildomar California 92595

Are you an adult with ADHD who has been taking medication for the past 6 months? You may be eligible to participate in a research study for an FDA approved medication.

Elite Clinical Trials, Inc.
Wildomar California 92595

Are you suffering from ADD/ADHD Symptoms? (Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder)

View More »

Pharmacology Research Institute
Encino California 91316

Patients are needed to participate in a clinical research study of SEP-225289 and Placebo to evaluate Adult Attention Deficit Hyperactivity Disorder

Collaborative Neuroscience Network Inc
Garden Grove California 92645

Patients are needed to participate in a clinical research study of SEP-225289 and Placebo to evaluate Adult Attention Deficit Hyperactivity Disorder

Bernardo Ng
Imperial California 92251
Updated

A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder

University of California at Irvine
Irvine California 92612

Patients are needed to participate in a clinical research study of SEP-225289 and Placebo to evaluate Adult Attention Deficit Hyperactivity Disorder

Pharmacology Research Institute
Los Alamitos California 90720

Patients are needed to participate in a clinical research study of SEP-225289 and Placebo to evaluate Adult Attention Deficit Hyperactivity Disorder

UCLA
Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating EMS 7500 Digital Muscle Stimulator for the treatment of Attention-Deficit/Hyperactivity Disorder

Synergy Clinical Research Center
National City California 91950
Updated

A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder

Synergy Clinical Research Center
National City California 91950
Updated

A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder

Pharmacology Research Institute
Newport Beach California 92660-2452

Patients are needed to participate in a clinical research study of SEP-225289 and Placebo to evaluate Adult Attention Deficit Hyperactivity Disorder

Pacific Sleep Medicine, A Medical Corporation
Oceanside California 92054
Updated

A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder

Excell Research, Inc
Oceanside California 92056

Patients are needed to participate in a clinical research study of SEP-225289 and Placebo to evaluate Adult Attention Deficit Hyperactivity Disorder

Neuropsychiatric Research Center for Orange County
Orange California 92868
Updated

A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder

SDS Clinical Trials, Inc.
Orange California 92868
Updated

A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder

Pacific Clinical Research Medical Group
Orange California 92868
Updated

A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder

Peninsula Research Associates
Rolling Hills Estates California 90274
Updated

A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder

Peninsula Research Associates, Inc.
Rolling Hills Estates California 90274
Updated

A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder

PCSD - Feighner Research
San Diego California 92108
Updated

A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder

PCSD - Feighner Research
San Diego California 92108
Updated

A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder

University of California, San Francisco
San Francisco California 94143
Updated

A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder

University of California, San Francisco
San Francisco California 94143
Updated

A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder

Neuropsychiatric Research Center of Orange County
Santa Ana California 92701
Updated

A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder

Neuropsychiatric Research Center of Orange County
Santa Ana California 92701

Patients are needed to participate in a clinical research study of SEP-225289 and Placebo to evaluate Adult Attention Deficit Hyperactivity Disorder

Robert Lipetz, DO
Spring Valley California 91978
Updated

A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder

Center for Healing the Human Spirit
Tarzana California 91356

A clinical trial seeking patients for a research study for the treatment of Attention Deficit/Hyperactivity Disorder

Eliot Moon, MD
Wildomar California 92595
Updated

A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder

Elite Clinical Trials
Wildomar California 92595
Updated

A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder

Colorado

IMMUNOe International Research Center
Centennial Colorado 80112
Updated

A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder

MCB Clinical Research Centers, LLC
Colorado Springs Colorado 80910
Updated

A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder

MCB Clinical Research Centers, LLC
Colorado Springs Colorado 80910
Updated

A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder

Connecticut

Coastal Connecticut Research, LLC
New London Connecticut 06320
Updated

A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder

Florida

View More »

Florida Clinical Research Center, LLC
Bradenton Florida 34201
Updated

A clinical research study of Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride and Placebo for the treatment of Attention-deficit/Hyperactivity Disorder

Florida Clinical Research Center, LLC
Bradenton Florida 34201

A clinical trial seeking patients for a research study for the treatment of ADHD

Florida Clinical Research Center
Bradenton Florida 34208

A Phase 3 clinical study for patients with Attention Deficit Hyperactivity Disorder (ADHD)

Florida Clinical Research Center, LLC
Bradenton Florida 34201
Updated

A Phase 4 clinical study for patients with Attention-deficit/Hyperactivity Disorder

Florida Clinical Research Center, LLC
Bradenton Florida 34201

Patients are needed to participate in a clinical research study evaluating TD-9855 and Placebo for the treatment of Attention-Deficit/Hyperactivity Disorder or ADHD

Florida Clinical Research Center, LLC
Bradenton Florida 34201

Patients are needed to participate in a clinical research study of SEP-225289 and Placebo to evaluate Adult Attention Deficit Hyperactivity Disorder

First 1 2 3 4 5 6 Last